University Medical Center Groningen Jun 4 2026 The drug finerenone significantly slows the decline in kidney function in patients with chronic kidney disease (CKD) who do not have diabetes.  This is shown by an international study led by clinical pharmacologist Hiddo Lambers Heerspink of the University Medical Center Groningen. This suggests that, for the first time, the drug is also effective in a large group of kidney patients who previously had fewer treatment options. The study results were